Therefore, assessment of IL-4 levels, eosinophilia and soluble VE-cadherin as a possible surrogate marker for endothelial barrier dysfunction might be useful tools to distinguish pirfenidone responders from patients at risk of disease exacerbation. Here, IL4 is linked to Increased total eosinophil count.